One of only two listed pawnbrokers in the UK, H&T may benefit from the economic slowdown as more people feel the need to pawn jewellery for cash, but most regular customers were fairly poor before the crunch. Its shares have fallen from 250p to 179p, but brokers believe the price should be nearer 260p Buy, says the Mail on Sunday.
Balfour Beatty describes itself as a world-class engineering, construction, services and investment group. It has suffered from association with the construction sector. But 50% of its business is in public sector work such as transport, education and health, which provide long-term, predictable revenue streams. Investors who get in now should reap plenty of rewards if they are patient. Buy, says the Mail on Sunday.
Venture capital group, 3i, delivered a solid pre-close update last week, noting that its strong first quarter had been supported by a robust second quarter. Everything is relative and the numbers looked weak compared with last year’s figures, which were delivered as the credit crisis took hold. However, 3i is now much better placed to cope with a downturn than it was at the last recession. Buy says the Telegraph’s Questor.
Drug developer Silence Therapeutics said this week that it was confident of signing new biotech and pharmaceutical collaborations in the next few months. Clearly, there is scope for a substantial uplift in Silence’s valuation. Buy, says Questor.
0.000p ()
